Zdrowie i gospodarka · 01/10/2018

FDA Releases Draft Guidance for Industry on Submission Requirements for Drug and Biologic Applications

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the necessary content and procedures for submissions related to risk analyses, human factors studies, and threshold analyses for new drug and biologic applications, including IND, NDA, BLA, and ANDA submissions.